Carolien Zeetsen

150 Solowij, N., Stephens, R.S., Roffman, R.A., Babor, T., Kadden, R., Miller, M., Christiansen, K., McRee, B., Vendetti, J., & the Marijuana Treatment Project Research Group. (2002). Cognitive functioning of long–term heavy cannabis users seeking treatment. Journal of the American Medical Association, 17 (8), 1123–1131. https://doi.org/10.1001/jama.287.9.1123 Spronk, D.B., van Wel, J.H.P., Ramaekers, J.G., & Verkes, R.J. (2013). Characterizing the cognitive effects of cocaine: a comprehensive review. Neuroscience and Biobehavioral Reviews, 37 (8), 1838–1859. https://doi.org/10.1016/j.neubiorev.2013.07.003 Stavro, K., Pelletier, J., & Potvin, S. (2013). Widespread and sustained cognitive deficits in alcoholism: a meta–analysis. Addiction Biology, 18 (2), 203–213. https://doi.org/10.1111/j.1369-1600.2011.00418.x Stevens, L., Verdejo–García, A., Goudriaan, A.E., Roeyers, H., Dom, G., & Vanderplasschen, W. (2014). Impulsivity as a vulnerability factor for poor addiction treatment outcomes: a review of neurocognitive findings among individuals with substance use disorders. Journal of Substance Abuse Treatment, 47 (1), 58–72. https://doi.org/10.1016/j.jsat.2014.01.008 Sugarman, M.A., & Axelrod, B.N. (2014). Utility of the Montreal Cognitive Assessment and Mini–Mental State Examination in predicting general intellectual abilities. Cognitive and Behavioral Neurology, 27 (3), 148–154. https://doi.org/10.1097/WNN.0000000000000035 Sumnall, H.R., Woolfall, K., Edwards, S., Cole, J.C., & Beynon, C.M. (2008). Use, function, and subjective experiences of Gamma–Hydroxybutyrate (GHB). Drug and Alcohol Dependence, 92 (1–3), 286–290. https://doi.org/10.1016/j.drugalcdep.2007.07.009 Teichner, G., Horner, M.D., Roitzsch, J.C., Herron, J., & Thevos, A. (2002). Substance abuse treatment outcomes for cognitively impaired and intact outpatients. Addictive Behaviors, 27 (5), 751–763. https://doi.org/10.1016/S0306-4603( 01)00207-6 Thissen, A.J.A.M., van Bergen, F., de Jonghe, J.F.M., Kessels, R.P.C., & Dautzenberg, P.L.J. (2010). Bruikbaarheid en validiteit van de Nederlandse versie van de Montreal Cognitive Assessment (MoCA–D) bij het diagnosticeren van Mild Cognitive Impairment [Applicability and validity of the Dutch version of the Montreal Cognitive Assessment (MoCA–D) in diagnosing Mild Cognitive Impairment]. Tijdschrift voor Gerontologie en Geriatrie, 41 (6), 231–240. https://doi.org/10.1007/s12439-010-0218-0 Thomann, A.E., Goettel, N., Monsch, R.J., Berres, M., Jahn, T., Steiner, L.A., & Monsch, A.U. (2018). The Montreal Cognitive Assessment: normative data from a German–speaking cohort and comparison with international normative samples. Journal of Alzheimer’s Disease, 64 (2), 643–655. https://doi. org/10.3233/JAD-180080 Toledo–Fernández, A., Brzezinski–Rittner, A., Roncero, C., Benjet, C., Salvador–Cruz, J., & Marín–Navarrete, R. (2018). Assessment of neurocognitive disorder in studies of cognitive impairment due to substance use disorder: a systematic review. Journal of Substance Use, 23 (5), 535–550. https:// doi.org/10.1080/14659891.2017.1397208 Tucker, K.A., Potenza, M.N., Beauvais, J.E., Browndyke, J.N., Gottschalk, P.C., & Kosten, T.R. (2004). Perfusion abnormalities and decision making in cocaine dependence. Biological Psychiatry, 56 (7), 527–530. https://doi.org/10.1016/j.biopsych.2004.06.031